Table 3.
Antibiotic (s) tested a | Sensitive | Resistant | ||
---|---|---|---|---|
(No.) | (%) | (No.) | (%) | |
AMC | 55 | 94.8 | 3 | 5.2 |
AMP | 45 | 77.6 | 13 | 22.4 |
ATM | 53 | 91.4 | 5 | 8.6 |
CAZ | 51 | 87.9 | 7 | 12.1 |
CEF | 57 | 98.2 | 1 | 1.8 |
CFM | 54 | 93.1 | 4 | 6.9 |
CHL | 48 | 82.2 | 10 | 17.2 |
CIP | 57 | 98.2 | 1 | 1.8 |
CRO | 54 | 93.1 | 3 | 6.9 |
CTX | 56 | 96.6 | 2 | 3.4 |
DTX | 13 | 22.4 | 45 | 77.5 |
GEN | 54 | 93.1 | 4 | 6.9 |
IMP | 58 | 100.0 | 0 | 0.0 |
KAN | 45 | 77.6 | 13 | 22.4 |
NAL | 15 | 25.9 | 43 | 74.1 |
NOR | 57 | 98.2 | 1 | 1.8 |
OT | 21 | 36.2 | 37 | 63.8 |
STR | 19 | 32.7 | 39 | 67.3 |
SXT | 46 | 79.4 | 12 | 20.6 |
AMC (20/10 µg), Amoxicillin-clavulanic acid; AMP (10 µg), Ampicillin; ATM (30 µg),Aztreonam; CAZ (30 µg), Ceftazidime; CEF (30 µg), Cefalothin; CFM (5 µg), Cefixime; CHL (30 µg), Chloramphenicol; CIP (5 µg), Ciprofloxacin; CRO (30 µg), Ceftriaxone; CTX (30 µg), Cefotaxime; DTX (30 µg), Doxycycline; GEN (10 µg), Gentamicin; IMP (10 µg), Imipenem; KAN (30 µg), Kanamycin; NAL (30 µg), Nalidixic acid; NOR (10 µg), Norfloxacin; OT (30 µg), Oxytetracycline; STR (10 µg), Streptomycin; SXT (25 µg), Trimethoprim- Sulfamethoxazole.